Format

Send to

Choose Destination
Front Immunol. 2014 Oct 30;5:552. doi: 10.3389/fimmu.2014.00552. eCollection 2014.

Immunity to cytomegalovirus in early life.

Author information

1
Institute for Medical Immunology, Université Libre de Bruxelles , Charleroi , Belgium.
2
Faculty of Pharmacy, Université Libre de Bruxelles , Brussels , Belgium.

Abstract

Cytomegalovirus (CMV) is the most common congenital infection and is the leading non-genetic cause of neurological defects. CMV infection in early life is also associated with intense and prolonged viral excretion, indicating limited control of viral replication. This review summarizes our current understanding of the innate and adaptive immune responses to CMV infection during fetal life and infancy. It illustrates the fact that studies of congenital CMV infection have provided a proof of principle that the human fetus can develop anti-viral innate and adaptive immune responses, indicating that such responses should be inducible by vaccination in early life. The review also emphasizes the fact that our understanding of the mechanisms involved in symptomatic congenital CMV infection remains limited.

KEYWORDS:

B lymphocytes; NK cells; cytomegalovirus; dendritic cells; fetus; infant; αβ T lymphocytes; γδ T lymphocytes

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center